{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:33Z","timestamp":1791409953362,"version":"4.3.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/nm.3512","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T19:45:14Z","timestamp":1395603914000},"page":"408-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":442,"title":["Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis"],"prefix":"10.1038","volume":"20","author":[{"given":"Rajasekhar N V S","family":"Suragani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M","family":"Cawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique V","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S","family":"Loveday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn W","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asya V","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Quisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Scott","family":"Pearsall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasbir","family":"Seehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,23]]},"reference":[{"key":"BFnm3512_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10428199509059614","volume":"18","author":"D Bowen","year":"1995","unstructured":"Bowen, D. What is ineffective erythropoiesis in myelodysplastic syndromes? Leuk. Lymphoma 18, 243\u2013247 (1995).","journal-title":"Leuk. Lymphoma"},{"key":"BFnm3512_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1182\/blood-2007-12-126938","volume":"112","author":"IV Libani","year":"2008","unstructured":"Libani, I.V. et al. Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in \u03b2-thalassemia. Blood 112, 875\u2013885 (2008).","journal-title":"Blood"},{"key":"BFnm3512_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1083\/jcb.200702080","volume":"177","author":"S Eshghi","year":"2007","unstructured":"Eshghi, S., Vogelezang, M.G., Hynes, R.O., Griffith, L.G. & Lodish, H.F. \u03b14\u03b21 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J. Cell Biol. 177, 871\u2013880 (2007).","journal-title":"J. Cell Biol."},{"issue":"suppl.","key":"BFnm3512_CR4","first-page":"S59","volume":"16","author":"RE Smith Jr.","year":"2010","unstructured":"Smith, R.E. Jr. The clinical and economic burden of anemia. Am. J. Manag. Care 16 (suppl.), S59\u2013S66 (2010).","journal-title":"Am. J. Manag. Care"},{"key":"BFnm3512_CR5","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1182\/blood-2011-07-356006","volume":"118","author":"SM Hattangadi","year":"2011","unstructured":"Hattangadi, S.M., Wong, P., Zhang, L., Flygare, J. & Lodish, H.F. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 118, 6258\u20136268 (2011).","journal-title":"Blood"},{"key":"BFnm3512_CR6","doi-asserted-by":"crossref","first-page":"358283","DOI":"10.1155\/2010\/358283","volume":"2010","author":"T Tanno","year":"2010","unstructured":"Tanno, T. & Miller, J.L. Iron loading and overloading due to ineffective erythropoiesis. Adv. Hematol. 2010, 358283 (2010).","journal-title":"Adv. Hematol."},{"key":"BFnm3512_CR7","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1182\/blood-2011-03-283614","volume":"118","author":"Y Ginzburg","year":"2011","unstructured":"Ginzburg, Y. & Rivella, S. \u03b2-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 118, 4321\u20134330 (2011).","journal-title":"Blood"},{"key":"BFnm3512_CR8","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.4081\/pr.2011.e17","volume":"3","author":"A Cao","year":"2011","unstructured":"Cao, A., Moi, P. & Galanello, R. Recent advances in \u03b2-thalassemias. Pediatr. Rep. 3, e17 (2011).","journal-title":"Pediatr. Rep."},{"key":"BFnm3512_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/cncr.23280","volume":"112","author":"E Jabbour","year":"2008","unstructured":"Jabbour, E., Kantarjian, H.M., Koller, C. & Taher, A. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes. Cancer 112, 1089\u20131095 (2008).","journal-title":"Cancer"},{"key":"BFnm3512_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20100305","volume":"429","author":"CC Rider","year":"2010","unstructured":"Rider, C.C. & Mulloy, B. Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem. J. 429, 1\u201312 (2010).","journal-title":"Biochem. J."},{"key":"BFnm3512_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/330765a0","volume":"330","author":"J Yu","year":"1987","unstructured":"Yu, J. et al. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330, 765\u2013767 (1987).","journal-title":"Nature"},{"key":"BFnm3512_CR12","doi-asserted-by":"publisher","first-page":"9052","DOI":"10.1073\/pnas.85.23.9052","volume":"85","author":"HE Broxmeyer","year":"1988","unstructured":"Broxmeyer, H.E. et al. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc. Natl. Acad. Sci. USA 85, 9052\u20139056 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3512_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/bbrc.1997.8020","volume":"242","author":"M Shiozaki","year":"1998","unstructured":"Shiozaki, M., Kosaka, M. & Eto, Y. Activin A: a commitment factor in erythroid differentiation. Biochem. Biophys. Res. Commun. 242, 631\u2013635 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3512_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0014-4827(02)00013-7","volume":"282","author":"V Maguer-Satta","year":"2003","unstructured":"Maguer-Satta, V. et al. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGF\u03b2 family. Exp. Cell Res. 282, 110\u2013120 (2003).","journal-title":"Exp. Cell Res."},{"key":"BFnm3512_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1634\/stemcells.21-5-557","volume":"21","author":"S Akel","year":"2003","unstructured":"Akel, S., Petrow-Sadowski, C., Laughlin, M.J. & Ruscetti, F.W. Neutralization of autocrine transforming growth factor-\u03b2 in human cord blood CD34+CD38\u2212Lin\u2212 cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation. Stem Cells 21, 557\u2013567 (2003).","journal-title":"Stem Cells"},{"key":"BFnm3512_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2009.04569.x","volume":"1176","author":"SS S\u00f6derberg","year":"2009","unstructured":"S\u00f6derberg, S.S., Karlsson, G. & Karlsson, S. Complex and context dependent regulation of hematopoiesis by TGF-\u03b2 superfamily signaling. Ann. NY Acad. Sci. 1176, 55\u201369 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm3512_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1634\/stemcells.20-6-493","volume":"20","author":"Y Shav-Tal","year":"2002","unstructured":"Shav-Tal, Y. & Zipori, D. The role of activin A in regulation of hemopoiesis. Stem Cells 20, 493\u2013500 (2002).","journal-title":"Stem Cells"},{"key":"BFnm3512_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/leu.2011.95","volume":"25","author":"U Blank","year":"2011","unstructured":"Blank, U. & Karlsson, S. The role of Smad signaling in hematopoiesis and translational hematology. Leukemia 25, 1379\u20131388 (2011).","journal-title":"Leukemia"},{"key":"BFnm3512_CR19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1073\/pnas.89.5.1553","volume":"89","author":"M Shiozaki","year":"1992","unstructured":"Shiozaki, M. et al. Evidence for the participation of endogenous activin A\/erythroid differentiation factor in the regulation of erythropoiesis. Proc. Natl. Acad. Sci. USA 89, 1553\u20131556 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3512_CR20","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2008-02-139824","volume":"112","author":"L Zhou","year":"2008","unstructured":"Zhou, L. et al. Inhibition of the TGF-\u03b2 receptor I kinase promotes hematopoiesis in MDS. Blood 112, 3434\u20133443 (2008).","journal-title":"Blood"},{"key":"BFnm3512_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/japplphysiol.00866.2009","volume":"109","author":"SM Cadena","year":"2010","unstructured":"Cadena, S.M. et al. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. J. Appl. Physiol. 109, 635\u2013642 (2010).","journal-title":"J. Appl. Physiol."},{"key":"BFnm3512_CR22","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1182\/blood-2011-10-388132","volume":"119","author":"RN Suragani","year":"2012","unstructured":"Suragani, R.N. et al. Heme-regulated eIF2\u03b1 kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood 119, 5276\u20135284 (2012).","journal-title":"Blood"},{"key":"BFnm3512_CR23","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1182\/blood.V98.12.3261","volume":"98","author":"M Socolovsky","year":"2001","unstructured":"Socolovsky, M. et al. Ineffective erythropoiesis in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice due to decreased survival of early erythroblasts. Blood 98, 3261\u20133273 (2001).","journal-title":"Blood"},{"key":"BFnm3512_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1182\/blood-2005-11-4458","volume":"108","author":"Y Liu","year":"2006","unstructured":"Liu, Y. et al. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 108, 123\u2013133 (2006).","journal-title":"Blood"},{"key":"BFnm3512_CR25","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1073\/pnas.0909296106","volume":"106","author":"K Chen","year":"2009","unstructured":"Chen, K. et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc. Natl. Acad. Sci. USA 106, 17413\u201317418 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3512_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ng0409-386","volume":"41","author":"C Camaschella","year":"2009","unstructured":"Camaschella, C. BMP6 orchestrates iron metabolism. Nat. Genet. 41, 386\u2013388 (2009).","journal-title":"Nat. Genet."},{"key":"BFnm3512_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/10320","volume":"22","author":"AC McPherron","year":"1999","unstructured":"McPherron, A.C., Lawler, A.M. & Lee, S.J. Regulation of anterior\/posterior patterning of the axial skeleton by growth\/differentiation factor 11. Nat. Genet. 22, 260\u2013264 (1999).","journal-title":"Nat. Genet."},{"key":"BFnm3512_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0896-6273(02)01172-8","volume":"37","author":"HH Wu","year":"2003","unstructured":"Wu, H.H. et al. Autoregulation of neurogenesis by GDF11. Neuron 37, 197\u2013207 (2003).","journal-title":"Neuron"},{"key":"BFnm3512_CR29","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1126\/science.1110175","volume":"308","author":"J Kim","year":"2005","unstructured":"Kim, J. et al. GDF11 controls the timing of progenitor cell competence in developing retina. Science 308, 1927\u20131930 (2005).","journal-title":"Science"},{"key":"BFnm3512_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2013.04.015","volume":"153","author":"FS Loffredo","year":"2013","unstructured":"Loffredo, F.S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828\u2013839 (2013).","journal-title":"Cell"},{"key":"BFnm3512_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","volume":"106","author":"YW Lin","year":"2005","unstructured":"Lin, Y.W., Slape, C., Zhang, Z. & Aplan, P.D. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 106, 287\u2013295 (2005).","journal-title":"Blood"},{"key":"BFnm3512_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MOH.0b013e32834521c8","volume":"18","author":"RF Paulson","year":"2011","unstructured":"Paulson, R.F., Shi, L. & Wu, D.C. Stress erythropoiesis: new signals and new stress progenitor cells. Curr. Opin. Hematol. 18, 139\u2013145 (2011).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnm3512_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.exphem.2012.12.002","volume":"41","author":"C Iancu-Rubin","year":"2013","unstructured":"Iancu-Rubin, C. et al. Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap. Exp. Hematol. 41, 155\u2013166.e17 (2013).","journal-title":"Exp. Hematol."},{"key":"BFnm3512_CR34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jcph.160","volume":"53","author":"ML Sherman","year":"2013","unstructured":"Sherman, M.L. et al. Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women. J. Clin. Pharmacol. 53, 1121\u20131130 (2013).","journal-title":"J. Clin. Pharmacol."},{"key":"BFnm3512_CR35","doi-asserted-by":"publisher","first-page":"21037","DOI":"10.1074\/jbc.M110.114959","volume":"285","author":"D Sako","year":"2010","unstructured":"Sako, D. et al. Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb. J. Biol. Chem. 285, 21037\u201321048 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm3512_CR36","first-page":"72","volume":"26","author":"HB Lee","year":"1985","unstructured":"Lee, H.B. & Blaufox, M.D. Blood volume in the rat. J. Nucl. Med. 26, 72\u201376 (1985).","journal-title":"J. Nucl. Med."},{"key":"BFnm3512_CR37","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1128\/MCB.20.16.6127-6137.2000","volume":"20","author":"AL Lau","year":"2000","unstructured":"Lau, A.L., Kumar, T.R., Nishimori, K., Bonadio, J. & Matzuk, M.M. Activin \u03b2C and \u03b2E genes are not essential for mouse liver growth, differentiation, and regeneration. Mol. Cell. Biol. 20, 6127\u20136137 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm3512_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI25227","volume":"116","author":"MP Menon","year":"2006","unstructured":"Menon, M.P. et al. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J. Clin. Invest. 116, 683\u2013694 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnm3512_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/1097-4644(20000915)78:4<588::AID-JCB8>3.0.CO;2-6","volume":"78","author":"RA Ignotz","year":"2000","unstructured":"Ignotz, R.A. & Honeyman, T. TGF-\u03b2 signaling in A549 lung carcinoma cells: lipid second messengers. J. Cell. Biochem. 78, 588\u2013594 (2000).","journal-title":"J. Cell. Biochem."},{"key":"BFnm3512_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker, M. et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120, 964\u2013972 (2007).","journal-title":"J. Cell Sci."},{"key":"BFnm3512_CR41","doi-asserted-by":"publisher","first-page":"27313","DOI":"10.1074\/jbc.M112.377960","volume":"287","author":"SA Townson","year":"2012","unstructured":"Townson, S.A. et al. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex. J. Biol. Chem. 287, 27313\u201327325 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnm3512_CR42","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1182\/blood-2006-10-051755","volume":"109","author":"CN Roy","year":"2007","unstructured":"Roy, C.N. et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109, 4038\u20134044 (2007).","journal-title":"Blood"},{"key":"BFnm3512_CR43","first-page":"e2809","volume":"54","author":"M Koulnis","year":"2011","unstructured":"Koulnis, M. et al. Identification and analysis of mouse erythroid progenitors using the CD71\/TER119 flow-cytometric assay. J. Vis. Exp. 54, \u2013e2809 (2011).","journal-title":"J. Vis. Exp."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3512","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:45:07Z","timestamp":1684449907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,23]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BFnm3512"],"URL":"https:\/\/doi.org\/10.1038\/nm.3512","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,23]]},"assertion":[{"value":"29 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.N.V.S.S., S.M. Cadena, S.M. Cawley, D.S., D.M., R.L., M.V.D., M.J.A., K.S.L., K.W.U., A.V.G., J.D.Q., R.S.P., J.S. and R.K. are current or former employees of Acceleron Pharma with ownership interest in the company. R.C. is an employee of Celgene with ownership interest in the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}